MedPath

浙江泰利森药业有限公司

Ownership
-
Established
1995-12-29
Employees
-
Market Cap
-
Website
www.tailison.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

22

NMPA:22

Drug Approvals

Pediatric Paracetamol,Atificial Cow-bezoar and Chlorphenamine Maleate Granules

Product Name
小儿氨酚黄那敏颗粒
Approval Number
国药准字H33021985
Approval Date
Sep 20, 2024
NMPA

杞枣口服液

Approval Number
国药准字B20020312
Approval Date
Sep 14, 2024
NMPA

Vinpocetine Tablets

Product Name
长春西汀片
Approval Number
国药准字H33022342
Approval Date
Aug 7, 2024
NMPA

Nifedipine Sustained-release Tablets(Ⅳ)

Product Name
纳欣同
Approval Number
国药准字H19991088
Approval Date
Jul 8, 2024
NMPA

Glimepiride Dispersible Tablets

Product Name
格列美脲分散片
Approval Number
国药准字H20140088
Approval Date
Jun 3, 2024
NMPA

Glimepiride Dispersible Tablets

Product Name
格列美脲分散片
Approval Number
国药准字H20140087
Approval Date
Jun 3, 2024
NMPA

Telmisartan Dispersible Tablets

Product Name
替米沙坦分散片
Approval Number
国药准字H20140032
Approval Date
Feb 7, 2024
NMPA

Telmisartan Dispersible Tablets

Product Name
替米沙坦分散片
Approval Number
国药准字H20140033
Approval Date
Feb 7, 2024
NMPA

喉舒宁胶囊

Approval Number
国药准字Z20080243
Approval Date
Jun 6, 2023
NMPA

复方苦木消炎胶囊

Approval Number
国药准字Z20080101
Approval Date
Nov 14, 2022
NMPA
  • Prev
  • 1
  • 2
  • 3
  • Next

Clinical Trials

No trials found

News

No news found
© Copyright 2025. All Rights Reserved by MedPath